Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Selective Estrogen Receptor Modulator”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Testing effectiveness (Phase 2)Study completedNCT00005879
What this trial is testing

LY353381 in Preventing Breast Cancer in Women With Hyperplasia

Who this might be right for
Breast Cancer
University of Kansas Medical Center 199
Testing effectiveness (Phase 2)Study completedNCT00365599
What this trial is testing

Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 43
Post-approval studies (Phase 4)Study completedNCT00361543
What this trial is testing

Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
The Alfred 54
Early research (Phase 1)Study completedNCT04080297
What this trial is testing

Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen

Who this might be right for
Vasomotor Symptoms (VMS)
Que Oncology 21
Early research (Phase 1)Study completedNCT01273168
What this trial is testing

Endoxifen in Adults With Hormone Receptor Positive Solid Tumors

Who this might be right for
Hormone Receptor-Positive BreastGynecologicDesmoid+1 more
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)UnknownNCT01352091
What this trial is testing

Adjuvant AI Combined With Zoladex

Who this might be right for
Breast Cancer
Fudan University 670
Post-approval studies (Phase 4)Study completedNCT01481883
What this trial is testing

Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
The Alfred 13
Not applicableUnknownNCT01973738
What this trial is testing

Comparison Between Raloxifene and Bazedoxifene

Who this might be right for
Selective Estrogen Receptor Modulator
Toshihiko Kono 300
Large-scale testing (Phase 3)Study completedNCT03043820
What this trial is testing

Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+1 more
Iris Sommer 110
Testing effectiveness (Phase 2)Study completedNCT00206557
What this trial is testing

The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
The Alfred 60
Post-approval studies (Phase 4)Looking for participantsNCT04113993
What this trial is testing

Bazedoxifene -Treatment for Women With Schizophrenia

Who this might be right for
SchizophreniaSchizophreniform DisordersSchizo Affective Disorder
The Alfred 160
Testing effectiveness (Phase 2)Study completedNCT00290251
What this trial is testing

Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914

Who this might be right for
Leiomyoma
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 72
Large-scale testing (Phase 3)Study completedNCT00534846
What this trial is testing

The Effect of Toremifene Treatment to the Magnetic Resonance Imaging (MRI) Findings in Premenstrual Mastalgia

Who this might be right for
Breast Pain
Satakunta Central Hospital 10
Not applicableStudy completedNCT00830973
What this trial is testing

The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer

Who this might be right for
Breast NeoplasmsTamoxifen
Medco Health Solutions, Inc. 184
Testing effectiveness (Phase 2)Study completedNCT02971761
What this trial is testing

Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer

Who this might be right for
Androgen Receptor PositiveEstrogen Receptor NegativeHER2/Neu Negative+3 more
City of Hope Medical Center 18
Post-approval studies (Phase 4)Study completedNCT03418831
What this trial is testing

Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women

Who this might be right for
Schizophrenia
Shanghai Mental Health Center 45
Not applicableStudy completedNCT03259711
What this trial is testing

Comparison of Cardiotoxicity Induced by Selective Estrogen REceptor Modulators and aNti-Aromatase

Who this might be right for
Cardiac Affections
Groupe Hospitalier Pitie-Salpetriere 20,000
Testing effectiveness (Phase 2)WithdrawnNCT02115594
What this trial is testing

Phase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast Cancer

Who this might be right for
Breast Cancer
Syndax Pharmaceuticals
Not applicableUnknownNCT02977949
What this trial is testing

The Effects of Seasonal Changes in Osteoporosis Treatment

Who this might be right for
Selective Estrogen Receptor Modulator (SERM)
Toshihiko Kono 200
Not applicableUnknownNCT00967239
What this trial is testing

Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2

Who this might be right for
Breast Cancer
NSABP Foundation Inc 1,881
Next Page